Vice President, Emerging Technologies
Corporate Office of Science & Technology
Johnson & Johnson

Dr. Smith is currently Vice President, Emerging Technologies for Johnson & Johnson in the Corporate Office of Science and Technology. His background includes an undergraduate degree in Electrical Engineering (EE) from Johns Hopkins University, a Master's degree in EE from the Massachusetts Institute of Technology (MIT), a PhD in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology, and an MD from Harvard Medical School. He completed his medical internship and residency at Brigham and Women's Hospital in Boston, and completed his cardiology and clinical electrophysiology training at Brigham and Women's hospital, the Krannert Institute of Cardiology in Indianapolis, and Washington University in St. Louis. From 1991 through 2000, he held academic positions at the School of Medicine (Cardiology) and the Department of Biomedical Engineering at Washington University in St. Louis and served as Associate Director of Cardiac Electrophysiology at Barnes Hospital. From there, he went on to found the Arrhythmia Institute in Fairfax Virginia, a center of excellence in clinical cardiac electrophysiology and clinical research. From January 2003 through December of 2006 he served as Senior VP and Chief Medical Officer of Guidant /Boston Scientific - Cardiac Rhythm Management, where he provided senior scientific and medical leadership in research and development, new product planning, clinical trial design and conduct, healthcare and reimbursement policy, and medical education. He joined Johnson & Johnson in 2007 as Vice President, Microelectronic Technologies for Cordis Corporation, a Johnson & Johnson company.

He has published in the areas of cardiac electrophysiology with special interest in ICD technology, catheter ablation, atrial fibrillation, and quantitative analytical techniques in biomedical signal processing, has been a consultant to many companies involved in the advancement of innovative medical technologies, and holds a number of patents in the area of signal processing and catheter and defibrillator design.